Literature DB >> 11912362

A comparison of glaucoma drainage implant tube coverage.

M Fran Smith1, J William Doyle, John W Ticrney.   

Abstract

PURPOSE: Surgeons may use various materials, including donor sclera, dura, or pericardium grafts to cover glaucoma drainage implant tubes, prior to repositioning conjunctiva. We reviewed our experience with these materials. PATIENTS AND METHODS: Sixty-four eyes with at least 24 months follow-up status post glaucoma drainage implant surgery were evaluated for signs of tube erosion, as well as patch graft thinning, after initial placement of donor sclera (23), dura (18), or pericardium (23) patch grafts.
RESULTS: Sixty-two eyes required no intervention for conjunctival and patch graft melting with subsequent tube erosion. Three cases (two eyes) of erosion requiring reoperation (1-dura at 6 months, 1-sclera at 15 months, and in the same eye 21 months later, 1-pericardium) were noted. Significant thinning of the donor patch graft such that the tube was visible beneath intact conjunctiva ocurred in 6 out of 23 donor sclera eyes, 4 out of 18 donor dura eyes, and 6 out of 23 donor pericardium eyes.
CONCLUSION: No material was more prone to melting than another. Donor sclera may be slightly more cost-efficient, but gamma-irradiated pericardium has sterility advantages.

Entities:  

Mesh:

Year:  2002        PMID: 11912362     DOI: 10.1097/00061198-200204000-00010

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  39 in total

1.  Measurement of Gamma-Irradiated Corneal Patch Graft Thickness After Aqueous Drainage Device Surgery.

Authors:  Regina A de Luna; Ameera Moledina; Jiangxia Wang; Henry D Jampel
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

2.  Baerveldt® glaucoma implant surgery with the double scleral flap technique to prevent Hoffman elbow exposure.

Authors:  Naoki Tojo; Tomoko Ueda-Consolvo; Shuichiro Yanagisawa; Atsushi Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-22       Impact factor: 3.117

3.  Glaucoma drainage devices: risk of exposure and infection.

Authors:  Joshua D Levinson; Annette L Giangiacomo; Allen D Beck; Paul B Pruett; Hillary M Superak; Michael J Lynn; Anastasios P Costarides
Journal:  Am J Ophthalmol       Date:  2015-05-30       Impact factor: 5.258

4.  Fibrin sealant-assisted revision of the exposed Ahmed tube.

Authors:  Nikhil S Choudhari; Aditya Neog; Supriya Latka; Bhaskar Srinivasan
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

5.  Scleral fixation of Ahmed glaucoma valve tube tip for adjustment of cornea-touching malposition.

Authors:  K T Ma; J H Kim; G J Seong; D S Jang; C Y Kim
Journal:  Eye (Lond)       Date:  2013-10-04       Impact factor: 3.775

6.  A novel application of amniotic membrane in patients with bullous keratopathy.

Authors:  Hyeon Il Lee; Sang Woo Ha; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

7.  Graft-free Ahmed tube insertion: a modified method at 5 mm from limbus.

Authors:  Juan Carlos Mesa-Gutiérrez; Juan Lillo-Sopena; Anna Monés-Llivina; Silvia Sanz-Moreno; Jorge Arruga-Ginebreda
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  Evaluation of Ahmed glaucoma valve implantation through a needle-generated scleral tunnel in Mexican children with glaucoma.

Authors:  Oscar Albis-Donado; Félix Gil-Carrasco; Rafael Romero-Quijada; Ravi Thomas
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

9.  Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up.

Authors:  Donald L Budenz; William J Feuer; Keith Barton; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys
Journal:  Am J Ophthalmol       Date:  2015-11-18       Impact factor: 5.258

10.  Tenon advancement and duplication technique to prevent postoperative Ahmed valve tube exposure in patients with refractory glaucoma.

Authors:  Nevbahar Tamcelik; Ahmet Ozkok; Ahmet Murat Sarıcı; Eray Atalay; Huseyin Yetik; Kivanc Gungor
Journal:  Jpn J Ophthalmol       Date:  2013-05-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.